[{"Assets_0_Q2_USD":4335386000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":258557000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":258584000.0,"StockholdersEquityConverted_0_Q2_USD":2714883000.0,"StockholdersEquity_0_Q2_USD":2686228000.0,"RevenuesConverted_2_Q2_USD":1392956000.0,"RevenuesConverted_1_Q2_USD":752157000.0,"NetIncomeLossConverted_2_Q2_USD":417623000.0,"NetIncomeLossConverted_1_Q2_USD":207360000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":574360000.0,"EarningsPerShareDiluted_2_Q2_USD":1.61,"EarningsPerShareDiluted_1_Q2_USD":0.8,"EarningsPerShareBasic_2_Q2_USD":1.65,"EarningsPerShareBasic_1_Q2_USD":0.82,"CommonStockSharesOutstanding_0_Q2_shares":254882837.0,"CommonStockSharesConverted_0_Q2_shares":254882837.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":254135000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":253685000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180726"}]